RUMC Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01695863
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

macrogol (1 trial)

polyethylene glycol (1 trial)

Drugs in Phase 3 Trials (1)

human fibrin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blood Loss, Surgical (Phase 3)

Colorectal Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3